Lori Hu

Lori Hu joined the Vertex Ventures Healthcare Palo Alto office in 2015 focusing on global healthcare investments. Prior to Vertex, Lori was an Associate Director for Business Development at Bristol-Myers Squibb, identifying and executing licensing, partnerships and transactions for the Chinese market. She has also worked with SR One, the corporate venture capital arm of GlaxoSmithKline in Boston. Previously, she was a strategy consultant in the health & life sciences practice at Accenture based across Singapore, China and South Africa. Lori graduated with an MBA from The Wharton School, and MA in International Studies from the University of Pennsylvania where she was a Leonard Lauder Fellow. She also holds a BSE in Biomedical Engineering from Duke University.